Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 47, 2019 - Issue 1
Submit an article Journal homepage
4,418
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway

Tianqi Lia Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China;b Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, ChinaView further author information
,
Yudi Xionga Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China;b Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, ChinaView further author information
,
Qingqing Wanga Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China;b Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, ChinaView further author information
,
Fengxia Chena Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China;b Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, ChinaView further author information
,
Yangyang Zenga Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China;b Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, ChinaView further author information
,
Xiaoyan Yua Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China;b Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, ChinaView further author information
,
Yuan Wanga Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China;b Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, ChinaView further author information
,
Fuxiang Zhoua Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China;b Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, ChinaView further author information
&
Yunfeng Zhoua Hubei Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital, Wuhan University, Wuhan, China;b Department of Radiation Oncology and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 4001-4011 | Received 01 Jul 2019, Accepted 26 Aug 2019, Published online: 07 Oct 2019

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.